NextSource CEO Robert DiCrisci Accused of Sexual Harassment, Spending Money on Strippers and Suits
Robert DiCrisci, CEO of the Miami-based pharmaceutical startup NextSource Biotechnology, was roundly criticized all over the world last week after the Wall Street Journal reported that NextSource had bought a 40-year-old brain-cancer drug and raised its maximum price to $768 per pill.